NASDAQ:DICE

DICE Therapeutics, Inc.

Stock

USD

Last Close

47.52

08/08 20:00

Market Cap

2.27B

Beta: -

Volume Today

4.33M

Avg: 534.33K

PE Ratio

−23.17

PFCF: −26.04

Overview Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21	Dec '22
revenue	5.78M -	863K 85.06%	1.13M 30.36%
cost of revenue
gross profit	5.78M -	863K 85.06%	1.13M 30.36%
selling and marketing expenses
general and administrative expenses	3.61M -	5.00M 38.73%	12.22M 144.24%	25.66M 109.97%
selling general and administrative expenses	3.61M -	5.00M 38.73%	12.22M 144.24%	25.66M 109.97%
research and development expenses	15.71M -	19.58M 24.59%	36.51M 86.45%	62.56M 71.37%
other expenses
cost and expenses	19.32M -	24.58M 27.23%	48.73M 98.21%	88.22M 81.05%
operating expenses	19.32M -	24.58M 27.23%	48.73M 98.21%	88.22M 81.05%
interest expense	26K -	13K 50%	174K 1,238.46%	679K 290.23%
ebitda	-12.21M -	-22.89M 87.49%	-47.47M 107.42%	-83.01M 74.88%
operating income	-13.55M -	-23.72M 75.10%	-47.60M 100.68%	-88.22M 85.33%
depreciation and amortization	1.34M -	836K 37.66%	136K 83.73%	5.21M 3,733.09%
total other income expenses net	609K -	-18K 102.96%	-1.36M 7,433.33%	4.33M 419.62%
income before tax	-12.94M -	-23.74M 83.48%	-48.96M 106.24%	-83.89M 71.34%
income tax expense	26K -	13K 50%	-487K 3,846.15%	-2.22M 356.47%
net income	-12.96M -	-23.75M 83.22%	-48.47M 104.08%	-81.66M 68.48%
weighted average shs out	23.23M -	23.23M 0%	12.38M 46.68%	39.40M 218.16%
weighted average shs out dil	23.23M -	23.23M 0%	12.38M 46.68%	39.40M 218.16%
eps	-0.56 -	-1.02 82.14%	-3.91 283.33%	-2.07 47.06%
epsdiluted	-0.56 -	-1.02 82.14%	-3.91 283.33%	-2.07 47.06%

All numbers in USD (except ratios and percentages)